pioglitazone (Actos) improves lipids better than rosiglitazone (Avandia)
August 2005
Reps will be touting new evidence that pioglitazone (Actos) improves lipids better than rosiglitazone (Avandia).
Both glitazones reduce A1C equally. But pioglitazone seems better at lowering triglycerides and increasing HDL.
Pioglitazone LOWERS triglycerides about 9% to 12%... rosiglitazone can INCREASE triglycerides up to 15%.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote